← Leaderboards
David T Rowe
University Of Pittsburgh At Pittsburgh
$2,301,504
Attributed
$2,301,504
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $501.5K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,301,504 · 1
By mechanism
P50$2,301,504 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Michael S. Diamond$85,358,908
- Charles R Rinaldo$100,535,685
- Cristian Apetrei$24,938,676
- Joseph C. Glorioso$19,383,290
- Dario Aa Vignali$40,087,127
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsImmunotherapyPolymerase Chain ReactionFlow CytometryHeart TransplantationImmune ResponseGene ExpressionBacterial InfectionsAutologous Dendritic CellsAntigens, ViralBlood CirculationB LymphocyteB-LymphocytesCategoriesBloodBehaviorAutologousCell TypeCharacteristicsChemotherapyChestChildChildhoodCells
Grant awards (5)
Transplant EBV Disease: Pathogenesis and Immunotherapy$403,932
P50 · FY2008 · HL · contact PI
Transplant EBV Disease: Pathogenesis and Immunotherapy$413,164
P50 · FY2007 · HL · contact PI
Transplant EBV Disease: Pathogenesis and Immunotherapy$501,505
P50 · FY2006 · HL · contact PI
Transplant EBV Disease: Pathogenesis and Immunotherapy$486,897
P50 · FY2005 · HL
Transplant EBV Disease: Pathogenesis and Immunotherapy$496,006
P50 · FY2004 · HL